Global Nausea And Vomiting Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 209584
  • calendar_today Published On: Oct, 2019
  • file_copy Pages: 100
  • list Pharmaceuticals and Healthcare

Description

Scope of the Report:

The global Nausea And Vomiting Treatment market is valued at 4435.7 million USD in 2018 and is expected to reach 5646.8 million USD by the end of 2024, growing at a CAGR of 6.2% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nausea And Vomiting Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Nausea And Vomiting Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nausea And Vomiting Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Merck & Co. Inc.

Taiji group

Kyowa Kirin

Helsinn Group

Teva Pharmaceutical Industries Ltd.

Unimed Pharmaceuticals (AbbVie Inc.)

Heron Therapeutics

Qilu Pharma

Sanofi

Novartis

Atnahs Pharma UK Limited

Tesaro

Mylan

Duchesnay

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Serotonin Receptor Antagonist

Neurokinin NK1 Receptor Antagonist

Other

Serotonin Receptor Antagonist had the biggest market share of 61% in 2018.

Market Segment by Applications, can be divided into

CINV

PONV

Motion Sickness

Pregnancy

Others

CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Nausea And Vomiting Treatment Market Overview

1.1 Product Overview and Scope of Nausea And Vomiting Treatment

1.2 Classification of Nausea And Vomiting Treatment by Types

1.2.1 Global Nausea And Vomiting Treatment Revenue Comparison by Types (2019-2024)

1.2.2 Global Nausea And Vomiting Treatment Revenue Market Share by Types in 2018

1.2.3 Serotonin Receptor Antagonist

1.2.4 Neurokinin NK1 Receptor Antagonist

1.2.5 Other

1.3 Global Nausea And Vomiting Treatment Market by Application

1.3.1 Global Nausea And Vomiting Treatment Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 CINV

1.3.3 PONV

1.3.4 Motion Sickness

1.3.5 Pregnancy

1.3.6 Others

1.4 Global Nausea And Vomiting Treatment Market by Regions

1.4.1 Global Nausea And Vomiting Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Nausea And Vomiting Treatment Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Nausea And Vomiting Treatment Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nausea And Vomiting Treatment Status and Prospect (2014-2024)

1.5 Global Market Size of Nausea And Vomiting Treatment (2014-2024)

2 Company Profiles

2.1 Merck & Co. Inc.

2.1.1 Business Overview

2.1.2 Nausea And Vomiting Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.2 Taiji group

2.2.1 Business Overview

2.2.2 Nausea And Vomiting Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.3 Kyowa Kirin

2.3.1 Business Overview

2.3.2 Nausea And Vomiting Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.4 Helsinn Group

2.4.1 Business Overview

2.4.2 Nausea And Vomiting Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.5 Teva Pharmaceutical Industries Ltd.

2.5.1 Business Overview

2.5.2 Nausea And Vomiting Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.6 Unimed Pharmaceuticals (AbbVie Inc.)

2.6.1 Business Overview

2.6.2 Nausea And Vomiting Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.7 Heron Therapeutics

2.7.1 Business Overview

2.7.2 Nausea And Vomiting Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.8 Qilu Pharma

2.8.1 Business Overview

2.8.2 Nausea And Vomiting Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Nausea And Vomiting Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.10 Novartis

2.10.1 Business Overview

2.10.2 Nausea And Vomiting Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.11 Atnahs Pharma UK Limited

2.11.1 Business Overview

2.11.2 Nausea And Vomiting Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.12 Tesaro

2.12.1 Business Overview

2.12.2 Nausea And Vomiting Treatment Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.13 Mylan

2.13.1 Business Overview

2.13.2 Nausea And Vomiting Treatment Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.14 Duchesnay

2.14.1 Business Overview

2.14.2 Nausea And Vomiting Treatment Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Nausea And Vomiting Treatment Market Competition, by Players

3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Nausea And Vomiting Treatment Players Market Share

3.2.2 Top 10 Nausea And Vomiting Treatment Players Market Share

3.3 Market Competition Trend

4 Global Nausea And Vomiting Treatment Market Size by Regions

4.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Regions

4.2 North America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

4.3 Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

4.5 South America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

5 North America Nausea And Vomiting Treatment Revenue by Countries

5.1 North America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)

5.2 USA Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

5.3 Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

5.4 Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

6 Europe Nausea And Vomiting Treatment Revenue by Countries

6.1 Europe Nausea And Vomiting Treatment Revenue by Countries (2014-2019)

6.2 Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

6.3 UK Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

6.4 France Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

6.5 Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

6.6 Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries

7.1 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries (2014-2019)

7.2 China Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

7.3 Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

7.4 Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

7.5 India Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

8 South America Nausea And Vomiting Treatment Revenue by Countries

8.1 South America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)

8.2 Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

8.3 Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

8.4 Colombia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Nausea And Vomiting Treatment by Countries

9.1 Middle East and Africa Nausea And Vomiting Treatment Revenue by Countries (2014-2019)

9.2 Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

9.3 UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

9.4 Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

9.5 Nigeria Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

9.6 South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)

10 Global Nausea And Vomiting Treatment Market Segment by Type

10.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Type (2014-2019)

10.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2019-2024)

10.3 Serotonin Receptor Antagonist Revenue Growth Rate (2014-2024)

10.4 Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2014-2024)

10.5 Other Revenue Growth Rate (2014-2024)

11 Global Nausea And Vomiting Treatment Market Segment by Application

11.1 Global Nausea And Vomiting Treatment Revenue Market Share by Application (2014-2019)

11.2 Nausea And Vomiting Treatment Market Forecast by Application (2019-2024)

11.3 CINV Revenue Growth (2014-2019)

11.4 PONV Revenue Growth (2014-2019)

11.5 Motion Sickness Revenue Growth (2014-2019)

11.6 Pregnancy Revenue Growth (2014-2019)

11.7 Others Revenue Growth (2014-2019)

12 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)

12.1 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)

12.2 Global Nausea And Vomiting Treatment Market Forecast by Regions (2019-2024)

12.3 North America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

12.4 Europe Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

12.6 South America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Nausea And Vomiting Treatment Picture

Table Product Specifications of Nausea And Vomiting Treatment

Table Global Nausea And Vomiting Treatment and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery